PM2.5 promotes platelet activation and thrombosis via ROS/MAPKs pathway-mediated mitochondrial dysfunction
Environmental Research · 2025
DOI: 10.1016/j.envres.2025.122116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Research, 2025. Verfasst von Yuquan Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160# PuJian Road, Shanghai, 200127, China; Department o…. Hauptthemen laut MEDLINE: Particulate Matter, Platelet Activation, Thrombosis, Mitochondria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: the Shanghai 3-year Public Health Action Plan, Natural Science Foundation of Shanghai Municipality, Shanghai International Science and Technology Partnership Project.
Abstract (Originalsprache)
Particulate matter (PM2.5) has been identified as a significant risk factor for the development of cardiovascular disease. The current work combined a human panel study with animal experiments intended to investigate the effects of ambient PM2.5 on platelet function and tried to figure out the potential mechanisms. The results showed that inhaling PM2.5 caused platelet aggregation in both human subjects and mouse models, resulting in changes to both the quantity and function of platelets. The multi-omics analysis showed that platelets stimulated by PM2.5 reduce the expression of the mitochondrial complex IV subunit cytochrome c oxidase subunit 1 (mt-COX1). In addition, PM2.5 may lead to an increase in platelet ROS, which activates the mitogen-activated protein kinases (MAPKs) pathway thereby promoting platelet activation and thrombosis. The antioxidant N-acetyl-L-cysteine (NAC) is found to reverse these changes in vitro. In conclusion, the present study provides evidence that exposure to ambient PM2.5 is associated with thrombosis by directly impairing platelet function, in which ROS/MAPKs pathway may be the potential target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 160# PuJian Road, Shanghai, 200127, China; Department of Cardiology, Ningbo Hangzhou Bay Hospital, Ningbo, Zhejiang, China.
- Department of Environmental Health, School of Public Health and the Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, China.
- Department of Environmental Health, School of Public Health and the Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, China; IRDR ICoE on Risk Interconnectivity and Governance on…
- NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Förderung
- the Shanghai 3-year Public Health Action Plan
- Natural Science Foundation of Shanghai Municipality
- Shanghai International Science and Technology Partnership Project
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Shanghai International Science and Technology
Zitieren
APA
Xie, Y., Fan, D., Wu, B., Guo, J., Wang, G., Yu, L., Zhang, C., Zhao, J., & Zhang, S. (2025). PM2.5 promotes platelet activation and thrombosis via ROS/MAPKs pathway-mediated mitochondrial dysfunction. Environmental Research. https://doi.org/10.1016/j.envres.2025.122116
Vancouver
Xie Y, Fan D, Wu B, Guo J, Wang G, Yu L, et al. PM2.5 promotes platelet activation and thrombosis via ROS/MAPKs pathway-mediated mitochondrial dysfunction. Environmental Research. 2025. doi:10.1016/j.envres.2025.122116
BibTeX
@article{Xie2025,
author = {Xie, Yuquan and Fan, Dongxia and Wu, Biao and Guo, Jianshu and Wang, Ge and Yu, Lu and Zhang, Chihang and Zhao, Jinzhuo and Zhang, Si},
title = {PM2.5 promotes platelet activation and thrombosis via ROS/MAPKs pathway-mediated mitochondrial dysfunction},
journal = {Environmental Research},
year = {2025},
doi = {10.1016/j.envres.2025.122116}
}
EUVIMED